S. 1095Introduced
Stop STALLING Act
Plain-English overview
What this bill does
Prohibits objectively baseless FDA citizen petitions used to delay competing drug approvals and treats them as unfair competition in the generic drug market
Key points
- Prohibit baseless FDA petitions
- Authorize FTC lawsuits
- Increase civil penalties
Current status
Where it stands
Status
Introduced
Latest action
2025-04-10 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.
